Serial #79324346
LIVE

Serial Number

79324346

Owner

HUB Organoids IP B.V.

Attorney

William C. Wright

Filing Date

Apr 29, 2021

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79324346 Trademark

Serial Number: 79324346 • Registration: 6909089

Serial #79324346 is a trademark filed by HUB Organoids IP B.V. on April 29, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HUB Organoids IP B.V. (6 trademarks)

Yalelaan 62

Entity Type: 78

HUB Organoids B.V. IP (6 trademarks)

Yalelaan 62

Entity Type: 99

Stichting Hubrecht Organoid Technology (6 trademarks)

Yalelaan 62

Entity Type: 78

Trademark Details

Filing Date

April 29, 2021

Registration Date

November 29, 2022

Published for Opposition

September 13, 2022

Goods & Services

Scientific research services; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development, characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine testing services, namely, testing of pharmaceuticals; compound, drug and vaccine testing services; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalised medicine

Cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; chemicals for use in scientific medical research for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; culture media for medical and veterinary use, namely, for use in diagnosis and treatment of diseases of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations and substances for the treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems, liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx

Cells, stem cells, and epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic and analytical preparations for use in science; chemicals used in science and industry; assays and assay preparations for scientific purposes; cell culture media for scientific research purposes

Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 28, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 28, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 28, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 28, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 28, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 28, 2025 COAR
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 7, 2024 ADCH
CHANGE OF OWNER RECEIVED FROM IB
Apr 5, 2024 CHLD
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Mar 19, 2024 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 10, 2024 INPR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Aug 15, 2023 NURC
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 10, 2023 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Jul 10, 2023 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 5, 2023 APRE
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 21, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 21, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2023 FICR
TEAS SECTION 7 REQUEST RECEIVED
Dec 19, 2022 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 29, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 29, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Sep 27, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 13, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 7, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 7, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 24, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 1, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 1, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 14, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 14, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 14, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 14, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 14, 2022 COAR
REFUSAL PROCESSED BY IB
Feb 20, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 3, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 3, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 14, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 13, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2021 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2021 NREP
APPLICATION FILING RECEIPT MAILED
Nov 9, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 5, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 4, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 28, 2021 REPR